130 related articles for article (PubMed ID: 35988448)
21. Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway.
Chie L; Amar S; Kung HF; Lin MC; Chen H; Chung DL; Adler V; Ronai Z; Friedman FK; Robinson RC; Kovac C; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2000; 45(6):441-9. PubMed ID: 10854130
[TBL] [Abstract][Full Text] [Related]
22. Senescence of human fibroblasts induced by oncogenic Raf.
Zhu J; Woods D; McMahon M; Bishop JM
Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
[TBL] [Abstract][Full Text] [Related]
23. Expression of human papilloma virus E7 protein causes apoptosis and inhibits DNA synthesis in primary hepatocytes via increased expression of p21(Cip-1/WAF1/MDA6).
Park JS; Boyer S; Mitchell K; Gilfor D; Birrer M; Darlington G; El Deiry W; Firestone GL; Munger K; Band V; Fisher PB; Dent P
J Biol Chem; 2000 Jan; 275(1):18-28. PubMed ID: 10617580
[TBL] [Abstract][Full Text] [Related]
24. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.
Rommel C; Clarke BA; Zimmermann S; Nuñez L; Rossman R; Reid K; Moelling K; Yancopoulos GD; Glass DJ
Science; 1999 Nov; 286(5445):1738-41. PubMed ID: 10576741
[TBL] [Abstract][Full Text] [Related]
25. P21(Cip1) induced by Raf is associated with increased Cdk4 activity in hematopoietic cells.
Chang F; McCubrey JA
Oncogene; 2001 Jul; 20(32):4354-64. PubMed ID: 11466616
[TBL] [Abstract][Full Text] [Related]
26. The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.
Polier G; Neumann J; Thuaud F; Ribeiro N; Gelhaus C; Schmidt H; Giaisi M; Köhler R; Müller WW; Proksch P; Leippe M; Janssen O; Désaubry L; Krammer PH; Li-Weber M
Chem Biol; 2012 Sep; 19(9):1093-104. PubMed ID: 22999878
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
[TBL] [Abstract][Full Text] [Related]
28. Discovery of 3,3'-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands.
Elderwish S; Audebrand A; Nebigil CG; Désaubry L
Eur J Med Chem; 2020 Jan; 186():111859. PubMed ID: 31735574
[TBL] [Abstract][Full Text] [Related]
29. Raf-induced cell cycle progression in human TF-1 hematopoietic cells.
Chang F; Steelman LS; McCubrey JA
Cell Cycle; 2002; 1(3):220-6. PubMed ID: 12429936
[TBL] [Abstract][Full Text] [Related]
30. Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.
Yang J; Li B; He QY
Cell Death Dis; 2018 May; 9(6):580. PubMed ID: 29784973
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process.
Yu C; Rahmani M; Almenara J; Sausville EA; Dent P; Grant S
Oncogene; 2004 Feb; 23(7):1364-76. PubMed ID: 14647418
[TBL] [Abstract][Full Text] [Related]
32. Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2.
Bali P; Pranpat M; Swaby R; Fiskus W; Yamaguchi H; Balasis M; Rocha K; Wang HG; Richon V; Bhalla K
Clin Cancer Res; 2005 Sep; 11(17):6382-9. PubMed ID: 16144943
[TBL] [Abstract][Full Text] [Related]
33. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
[TBL] [Abstract][Full Text] [Related]
34. Human alphaA- and alphaB-crystallins prevent UVA-induced apoptosis through regulation of PKCalpha, RAF/MEK/ERK and AKT signaling pathways.
Liu JP; Schlosser R; Ma WY; Dong Z; Feng H; Liu L; Huang XQ; Liu Y; Li DW
Exp Eye Res; 2004 Sep; 79(3):393-403. PubMed ID: 15336502
[TBL] [Abstract][Full Text] [Related]
35. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
36. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic.
Tombes RM; Auer KL; Mikkelsen R; Valerie K; Wymann MP; Marshall CJ; McMahon M; Dent P
Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1451-60. PubMed ID: 9494119
[TBL] [Abstract][Full Text] [Related]
37. A novel antiproliferative PKCα-Ras-ERK signaling axis in intestinal epithelial cells.
Kaur N; Lum MA; Lewis RE; Black AR; Black JD
J Biol Chem; 2022 Jul; 298(7):102121. PubMed ID: 35697074
[TBL] [Abstract][Full Text] [Related]
38. Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway.
Chowdhury I; Thompson WE; Thomas K
J Cell Physiol; 2014 Aug; 229(8):998-1004. PubMed ID: 24347342
[TBL] [Abstract][Full Text] [Related]
39. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
Aziz N; Cherwinski H; McMahon M
Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines.
Mazzocca A; Giusti S; Hamilton AD; Sebti SM; Pantaleo P; Carloni V
Mol Pharmacol; 2003 Jan; 63(1):159-66. PubMed ID: 12488548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
